Paper Details

  1. Home
  2. Paper Details

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.

Author: , ArcherDavid F, AyotteNormand, BalserJohn, BeauregardAdam, BouchardCéline, CusanLeonello, CôtéIsabelle, DerogatisLeonard, GallagherJohn, GirardGinette, LabrieFernand, LavoieLyne, MartelCéline, MoyneurErick, PortmanDavid, VaillancourtMario

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Intravaginal DHEA is a potential treatment for improving sexual function in postmenopausal women.
Paper Details　
Original Abstract of the Article :
Intravaginal DHEA (dehydroepiandrosterone, prasterone), the exclusive precursor of androgens and estrogens in postmenopausal women, has previously been shown to improve all the domains of sexual function by a strictly local action in the vagina. The well recognized female sexual function index (FSFI...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/26725467

データ提供：米国国立医学図書館（NLM）

Intravaginal DHEA for Female Sexual Function in Postmenopausal Women

This open-label study investigates the effects of intravaginal dehydroepiandrosterone (DHEA) on female sexual function in postmenopausal women. Previous research indicated that DHEA can improve sexual function through a local action in the vagina. This study used the Female Sexual Function Index (FSFI) questionnaire to assess the impact of intravaginal DHEA on sexual function in postmenopausal women.

Exploring the Potential of Intravaginal DHEA

The study aims to provide further evidence regarding the effectiveness of intravaginal DHEA in improving sexual function in postmenopausal women. This research can contribute to understanding potential treatment options for sexual dysfunction in this population.

Navigating the Desert of Menopause: A Search for Solutions

Menopause can present a challenging landscape of physical and emotional changes. This study explores the potential of intravaginal DHEA as a treatment option for sexual dysfunction associated with menopause, offering a glimmer of hope for improving sexual health and well-being in postmenopausal women.

Dr.Camel's Conclusion

This study provides further evidence for the potential of intravaginal DHEA as a treatment for sexual dysfunction in postmenopausal women. It highlights the importance of exploring alternative treatment options to address the challenges associated with menopause, ultimately contributing to improved sexual health and overall well-being.

Date :
  1. Date Completed 2016-12-13
  2. Date Revised 2016-12-30
Further Info :

Pubmed ID

26725467

DOI: Digital Object Identifier

/j/hmbci.ahead-of-print/hmbci-2015-0044/hmbci-2015-0044.xml

Related Literature

Article Analysis
・Effects of prasterone vaginal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.